Chiratae Ventures invests in Aether Biomedical
The company said the funding will primarily be used for the commercialization of its first product Zeus, a multi-functional hand bionic prosthesis, across India and Europe.
The company also aims to continue its research and development efforts by building the next generation of the bionic limb and building
Aether Biomedical, founded by Dhruv Agrawal and Faith Jiwakhan, claims that Zeus is a low-cost, high efficacy product aimed to create data-driven rehabilitation accessible and more robust. Their state-of-the-art product offers one of the highest grip forces in the market and is priced at a much affordable rate to bring a larger set of amputees under their purview.
"Building at the intersection of robotics, mechatronics, research, insights & innovation we hope our solutions help 10 M+ amputees globally live better lives & re-invent medical tech," adds Agrawal.
The investment is part of Chiratae's DeepTech Innovators Program which is in its sixth edition.
"We see deep-tech playing a pivotal role in shaping scalable solutions across verticals. As technology evolves so does the benchmark for innovation, Aether & its team is a great example of that," said Sudhir Sethi, founder & managing director, Chiratae Ventures.